Somantadine
![]() | |
| Clinical data | |
|---|---|
| Other names | PR 741-976; a,a-Dimethyl-1-adamantaneethylamine; [2-(1-Adamantyl)-1,1-dimethylethyl]amine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H25N |
| Molar mass | 207.361 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Somantadine (INN; developmental code name PR 741-976), or somantadine hydrochloride (USAN) in the case of the hydrochloride salt, is an experimental antiviral drug of the adamantane family related to amantadine and rimantadine that was never marketed.[1][2][3] It was first described by 1978.[1]
References
- ^ a b Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 2. ISBN 978-1-4757-2085-3. Retrieved 13 September 2024.
- ^ Milne GW (2017). Ashgate Handbook of Anti-Infective Agents: An International Guide to 1, 600 Drugs in Current Use: An International Guide to 1, 600 Drugs in Current Use. Routledge Revivals. Taylor & Francis. p. 294. ISBN 978-1-351-73490-5. Retrieved 13 September 2024.
- ^ Negwer M (1994). Organic-chemical Drugs and Their Synonyms: (an International Survey). Akademie Verlag. p. 943. ISBN 978-3-05-500156-7. Retrieved 13 September 2024.
